| Synonyms: | |
| Status: | Approved (1994) |
| Entry Type: | Small molecule |
| Molecule Category: | Parent |
| ATC: | L01CA04 |
| UNII: | Q6C979R91Y |
| InChI Key | GBABOYUKABKIAF-IELIFDKJSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C45H54N4O8 |
| Molecular Weight | 778.95 |
| AlogP | 4.75 |
| Hydrogen Bond Acceptor | 11.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 7.0 |
| Polar Surface Area | 133.87 |
| Molecular species | BASE |
| Aromatic Rings | 3.0 |
| Heavy Atoms | 57.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Hydrolase
|
- | - | - | - | 0 | |
|
Structural protein
|
- | 700-2000 | - | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Neoplasms | 4 | D009369 | ClinicalTrials |
| Neoplasms | 4 | D009369 | ClinicalTrials |
| Esophageal Neoplasms | 3 | D004938 | ClinicalTrials |
| Lymphoma, Non-Hodgkin | 3 | D008228 | ClinicalTrials |
| Rhabdomyosarcoma, Alveolar | 3 | D018232 | ClinicalTrials |
| Rhabdomyosarcoma, Embryonal | 3 | D018233 | ClinicalTrials |
| Mesothelioma | 3 | D008654 | ClinicalTrials |
| Lung Neoplasms | 3 | D008175 | ClinicalTrials |
| Mesothelioma | 3 | D008654 | ClinicalTrials |
| Uterine Cervical Neoplasms | 3 | D002583 | ClinicalTrials |
| Breast Neoplasms | 3 | D001943 | ClinicalTrials |
| Carcinoma | 3 | D002277 | ClinicalTrials |
| Lung Neoplasms | 3 | D008175 | ClinicalTrials |
| Breast Neoplasms | 3 | D001943 | ClinicalTrials |
| Lung Neoplasms | 3 | D008175 | ClinicalTrials |
| Carcinoma, Non-Small-Cell Lung | 3 | D002289 | ClinicalTrials |
| Hodgkin Disease | 2 | D006689 | ClinicalTrials |
| Melanoma | 2 | D008545 | ClinicalTrials |
| Hodgkin Disease | 2 | D006689 | ClinicalTrials |
| Lymphoma, Large B-Cell, Diffuse | 2 | D016403 | ClinicalTrials |
| Sarcoma | 2 | D012509 | ClinicalTrials |
| Multiple Myeloma | 2 | D009101 | ClinicalTrials |
| Melanoma | 2 | D008545 | ClinicalTrials |
| Lymphoma, Large-Cell, Anaplastic | 2 | D017728 | ClinicalTrials |
| Carcinoma, Large Cell | 2 | D018287 | ClinicalTrials |
| Head and Neck Neoplasms | 2 | D006258 | ClinicalTrials |
| Adenocarcinoma of Lung | 2 | D000077192 | ClinicalTrials |
| Rhabdomyosarcoma | 2 | D012208 | ClinicalTrials |
| Triple Negative Breast Neoplasms | 2 | D064726 | ClinicalTrials |
| Diffuse Intrinsic Pontine Glioma | 2 | D000080443 | ClinicalTrials |
| Fallopian Tube Neoplasms | 2 | D005185 | ClinicalTrials |
| Ovarian Neoplasms | 2 | D010051 | ClinicalTrials |
| Prostatic Neoplasms, Castration-Resistant | 1 | D064129 | ClinicalTrials |
| Desmoplastic Small Round Cell Tumor | 1 | D058405 | ClinicalTrials |
| Small Cell Lung Carcinoma | 1 | D055752 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 71486-22-1 |
| ChEBI | 480999 |
| ChEMBL | CHEMBL553025 |
| DrugBank | DB00361 |
| DrugCentral | 2827 |
| EPA CompTox | DTXSID8040640 |
| FDA SRS | Q6C979R91Y |
| Guide to Pharmacology | 7105 |
| PubChem | 5311497 |
| SureChEMBL | SCHEMBL4765 |
| ZINC | ZINC000085536958 |